Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database.
Naik, Marcel G; Heller, Katharina M; Arns, Wolfgang; Budde, Klemens; Diekmann, Fritz; Eitner, Frank; Fischereder, Michael; Goßmann, Jan; Heyne, Nils; Morath, Christian; Riester, Udo; Gwinner, Wilfried; Jürgensen, Jan Steffen.
; 28(1): 67-79, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24372584
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.
Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients.
Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study.
Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus.
Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation.
Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study.
Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS study.
Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus.
Trends in immunosuppression after pancreas transplantation: what is in the pipeline?